Arrhythmia Detection After MI

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
Samir Saba
Study ID
NCT05073419
Status
Recruiting
Apply to this trial

Conditions

  • Acute Myocardial Infarction

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Standard of Care — OTHER
    Routine monitoring of post AMI patient with clinic visits
  • ICM Implantation — DEVICE
    Implantation of ICM through small incision (2 mm) under the skin

Study Details

Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.

Key Dates

Start date
Aug 9, 2022
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Control
    Post-AMI patients in this arm will receive standard of care
  • Experimental: ICM
    Post-AMI patients in this arm will receive standard of care and an ICM

Primary Outcome Measure

Changes to patient management [ Time Frame: 90 days post AMI ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UPMC Presbyterian HospitalPittsburghPennsylvania15213
Eric Pasquantonio
[email protected]
14126478210

Find similar trials in Pittsburgh, PA

By research site
UPMC Presbyterian Hospital· Pittsburgh, PA

Related Studies